BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a naturally occurring protein in the body and is commonly discussed for its role in supporting natural repair and recovery processes
This is particularly important in cell culture research, where serum-containing media harbors significant IGFBP concentrations that would rapidly sequester native IGF-1 and attenuate its signaling
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine
MK-677 research in mice, appeared to prevent the onset of Alzheimers disease, even in genetically predisposed mice, as long as it was started before significant amyloid beta accumulation
Stability Active in acidic environments Unlike conventional peptides, BPC-157 remains stable for more than 24 hours in gastric juice
Diana Harshbarger (R-Tenn.), who is also a pharmacist and has asked the FDA to ease up on peptide regulation